S
Sarah E. Bohndiek
Researcher at University of Cambridge
Publications - 176
Citations - 5551
Sarah E. Bohndiek is an academic researcher from University of Cambridge. The author has contributed to research in topics: Medicine & Hyperspectral imaging. The author has an hindex of 30, co-authored 141 publications receiving 4254 citations. Previous affiliations of Sarah E. Bohndiek include Engineering and Physical Sciences Research Council & University College London.
Papers
More filters
Journal ArticleDOI
Noninvasive hemoglobin sensing and imaging: optical tools for disease diagnosis
TL;DR: This work compared and contrasted the ability of different methods to determine hemoglobin biomarkers such as oxygenation while considering factors that influence their practical application and highlighted key limitations in the current state-of-the-art.
Journal ArticleDOI
Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent.
Zoltan Szucs,James Joseph,James Joseph,Tim J. Larkin,Bangwen Xie,Sarah E. Bohndiek,Kevin M. Brindle,André A. Neves +7 more
TL;DR: In this paper, the distribution and extent of comedo-type necrosis in a model of human Ductal carcinoma in situ (DCIS) using C2Am, an imaging agent that binds to the phosphatidylserine exposed by necrotic cells, was described.
Posted ContentDOI
Co-Registration of Optoacoustic Tomography and Magnetic Resonance Imaging Data from Murine Tumour Models
Marcel Gehrung,Michal R. Tomaszewski,Dominick J.O. McIntyre,Jonathan A. Disselhorst,Sarah E. Bohndiek +4 more
TL;DR: This framework combines a novel MR animal holder, to improve animal positioning for deformable tissues, and a landmark-based software co-registration algorithm that significantly improves registration of both body and tumour contours between these modalities.
Proceedings ArticleDOI
Application of confocal Raman micro-spectroscopy for label-free monitoring of oxidative stress in living bronchial cells
TL;DR: The results suggest that confocal Raman micro-spectroscopy may be able to monitor the biological impact of oxidative and reductive processes in cells, hence enabling longitudinal studies of oxidative stress in therapy resistance and metastasis at the single cell level.
Proceedings ArticleDOI
Cellulose nanoparticles: photoacoustic contrast agents that biodegrade to simple sugars
TL;DR: This work describes a cellulose-based nanoparticle with photoacoustic signal superior to gold nanorods, but that undergoes enzymatic cleavage into constituent glucose molecules for renal clearance, the first example of a sugar-based photoac acoustic contrast agent with important implications for clinical translation of this emerging molecular imaging modality.